Ginkgo Bioworks Holdings (DNA) Retained Earnings (2021 - 2026)

Ginkgo Bioworks Holdings (DNA) has 6 years of Retained Earnings data on file, last reported at -$6.2 billion in Q1 2026.

• For the quarter ending Q1 2026, Retained Earnings fell 733183.18% year-over-year to -$6.2 billion; the trailing twelve-month figure through Mar 2026 stood at -$6.2 billion (down 733183.18% YoY), and the FY2025 full-year result was -$6.2 billion, down 340449.28% from the prior year.
• Retained Earnings for Q1 2026 stood at -$6.2 billion, down from -$6.2 billion in the prior quarter.
• Across five years, Retained Earnings topped out at $5.2 million in Q1 2022 and bottomed at -$6.2 billion in Q1 2026.
• The 5-year median for Retained Earnings is -$1.6 million (2024), against an average of -$1.6 billion.
• The widest annual swing landed in 2025, when Retained Earnings surged 658.94%; it then tumbled 733183.18% in 2026.
• A 5-year view of Retained Earnings shows it stood at -$4.4 billion in 2022, then jumped by 100.03% to $1.5 million in 2023, then tumbled by 221.7% to -$1.8 million in 2024, then slumped by 340449.28% to -$6.2 billion in 2025, then dropped by 1.34% to -$6.2 billion in 2026.
• The last three Retained Earnings figures came in at -$6.2 billion (Q1 2026), -$6.2 billion (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.

Peer Comparison